University of Virginia Health System

Skip Navigation
  • Health System
  • Calendars
  • Maps
  • A-Z Index
  • UVa
  • BMBG Group
  • Program Overview
  • Information for Prospective Students
  • Faculty Mentors
    • Chromatin Structure and Gene Activity
    • Macromolecular Structure and Function
    • The Cell Cycle and Cellular Regulation
    • Molecular Mechanisms of Human Disease
    • Affiliated Faculty
    • Dept Medicine Fellows Program
  • Graduate Student Handbook
  • Student Rotations
  • Student Directory, Photos, Publications, & Alumni
    • Student Alphabetical Listing
    • 1st Yeat Student Photos
    • Student Photos
    • Working in the lab
    • Current Student Publications
    • Alumni Student Publications
    • Alumni
  • Seminar Schedule
  • Journal Club Schedule
  • Biomedical Sciences Graduate Programs
    • Biochemistry, Molecular Biology and Genetics
    • Biomedical Engineering
    • Molecular Cell and Developmental Biology
    • Molecular Medicine (Physiology, Pharmacology, Pathology)
    • Microbiology, Immunology and Infectious Diseases
    • Neuroscience
    • Structural Computational Biology, and Biophysics
  • Contact Us
  • Search this Site
    View the Site Index
New Program!

Blood



Adam Kennedy link to other pubmed listings for this student
2003 Feb 1;101(3):1071-9. Epub 2002 Sep 5
An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab.

Last modified on: November 1, 2006

  • Print this Page
  • E-mail this Page

Biomedical Sciences: Biochemistry, Molecular Biology & Genetics

PO Box 800738

Charlottesville, VA 22908

434-924-1997

Maintained by BMBG Group

© 2008 by the Rector and Visitors of the University of Virginia

Disclaimer | About this Site